ACROBiosystems | 卵巢癌CAR Therapy有希望的目標

ACROBiosystems | 卵巢癌CAR Therapy有希望的目標


本文轉載自原廠電子報:ACROBiosystems |


Promising Targets of CAR Therapy for Ovarian Cancer

Ovarian cancer, as a common gynecological tumor, is currently recognized as the most lethal gynecological malignancy. Several preclinical experiments and clinical trials have confirmed that adoptive cell immunotherapy using typical CAR-engineered T cells for OC is a promising treatment approach with striking clinical efficacy. The most popular targets for CAR-T cell therapy of ovarian cancer include
,HER2and MUC16.




MSLN is highly expressed in multiple solid tumors, such as ovarian cancer, lung adenocarcinoma, and breast cancer. Considering its low expression on normal mesothelial cells and high expression in ovarian cancer, MSLN is a promising target of CAR T therapy for ovarian cancer.




More than 80% of ovarian cancer is characterized by overexpression of MUC16, and the high expression of MUC16 is an important indicator for the early diagnosis of ovarian cancer. Studies have shown that MUC16-CAR-T cells have specific killing effects on MUC16+ ovarian cancer cells in vitro.



Overexpression and amplification of HER2 is observed in 5-66% of epithelial ovarian cancer, making it an ideal target for ovarian cancer treatment. At present, HER2-specific CAR-T cell therapy has shown good therapeutic potential in the preclinical stage.

Hot products




Detection of Anti-MSLN CAR Expression

Cat. No. MSN-HF223

Product: FITC-Labeled Human Mesothelin (296-580), His Tag




293 cells were transfected with anti-MSLN-scFv and RFP tag. 2e5 of the cells were stained with FITC-Labeled Human Mesothelin (296-580), His Tag (Cat. No. MSN-HF223, 1 μg/mL) and FITC-labeled protein control. Non-transfected 293 cells and FITC-labeled protein control were used as negative control. RFP was used to evaluate CAR (anti-MSLN-scFv) expression and FITC was used to evaluate the binding activity of FITC-Labeled Human Mesothelin (296-580), His Tag (Cat. No. MSN-HF223).

FACS Analysis of Anti-HER2 CAR Expression

Cat. No. HE2-HF224

Product: FITC-Labeled Human Her2, His Tag


FACS Analysis of Anti-HER2 CAR Expression

Cat. No. HE2-HF224

Product: FITC-Labeled Human Her2, His Tag

Time Limited Promotion: What Mystery Box Will You Get?





Life is like a mystery box, you will never know what to expect inside!


Place any order that is greater than $500 from Jan 25th to Feb 15th, you will receive a mystery box from us!



LINE 線上諮詢



error: Content is protected !!